Hyundai Pharmaceutical (004310.KS) Earnings Analysis
Hyundai Pharmaceutical (004310.KS) has no confirmed upcoming earnings date. Trailing P/E 38.69.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 004310.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 004310.KS. This page updates as the calendar is published.
004310.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-02-27 | -37.69839 KRW | n/a | n/a | n/a |
| 2024-11-30 | -57.62777 KRW | n/a | n/a | n/a |
| 2024-08-29 | -19 KRW | n/a | n/a | n/a |
004310.KS valuation and analyst view
| Trailing P/E | 38.69 |
|---|---|
| Trailing EPS | 143.75 KRW |
| Price / book | 1.52 |
| Dividend yield | 0.48% |
| Market cap | 152.66B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hyundai Pharmaceutical (004310.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 004310.KS. This page updates as the calendar is published.
Did 004310.KS beat earnings last quarter?
Consensus estimate data was not available for 004310.KS's 2025-02-27 report.
What is 004310.KS's current P/E ratio and EPS?
004310.KS trades at a trailing P/E of 38.69 on trailing EPS of 143.75384362941656 KRW.
What do analysts rate 004310.KS?
004310.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.